celecoxib has been researched along with Neutropenia in 3 studies
Neutropenia: A decrease in the number of NEUTROPHILS found in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Neutropenia was the main side effect of the metronomic therapy." | 5.38 | Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy. ( Kivivuori, SM; Nygaard, R, 2012) |
| "Celecoxib with CCRT was well tolerated; the incidence of symptomatic radiation pneumonitis was 6." | 2.90 | Effect of Concurrent Chemoradiation With Celecoxib vs Concurrent Chemoradiation Alone on Survival Among Patients With Non-Small Cell Lung Cancer With and Without Cyclooxygenase 2 Genetic Variants: A Phase 2 Randomized Clinical Trial. ( Bi, N; Chen, D; Deng, L; Feng, Q; Fu, Z; Hu, C; Hui, Z; Liang, J; Liu, L; Lv, J; Wang, J; Wang, L; Wang, W; Wang, X; Xiao, Z; Yang, X; Zhang, T; Zhou, Z, 2019) |
| "Unresectable pancreatic cancer has few therapeutic options and a dismal prognosis." | 2.71 | Gemcitabine/Irinotecan/celecoxib in pancreatic cancer. ( Campbell, C; Harvey, H; Kerr, S; Legore, K; Lipton, A; Witters, L, 2004) |
| "Neutropenia was the main side effect of the metronomic therapy." | 1.38 | Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy. ( Kivivuori, SM; Nygaard, R, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, N | 1 |
| Liang, J | 1 |
| Zhou, Z | 1 |
| Chen, D | 1 |
| Fu, Z | 1 |
| Yang, X | 1 |
| Feng, Q | 1 |
| Hui, Z | 1 |
| Xiao, Z | 1 |
| Lv, J | 1 |
| Wang, X | 2 |
| Zhang, T | 1 |
| Deng, L | 1 |
| Wang, W | 1 |
| Wang, J | 1 |
| Liu, L | 1 |
| Hu, C | 1 |
| Wang, L | 1 |
| Nygaard, R | 1 |
| Kivivuori, SM | 1 |
| Lipton, A | 1 |
| Harvey, H | 1 |
| Witters, L | 1 |
| Kerr, S | 1 |
| Legore, K | 1 |
| Campbell, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Phase II Trial of Cisplatin/Etoposide and Concurrent Radiotherapy With or Without Celecoxib in Patients With Unresectable Locally Advanced Non-small Cell Lung Cancer[NCT01503385] | Phase 2 | 100 participants (Anticipated) | Interventional | 2011-12-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for celecoxib and Neutropenia
| Article | Year |
|---|---|
Effect of Concurrent Chemoradiation With Celecoxib vs Concurrent Chemoradiation Alone on Survival Among Patients With Non-Small Cell Lung Cancer With and Without Cyclooxygenase 2 Genetic Variants: A Phase 2 Randomized Clinical Trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Celecoxib; Chemoradi | 2019 |
Gemcitabine/Irinotecan/celecoxib in pancreatic cancer.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Ch | 2004 |
1 other study available for celecoxib and Neutropenia
| Article | Year |
|---|---|
Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy.
Topics: Administration, Metronomic; Adolescent; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherap | 2012 |